The median tumor-free survival time in patients with low ERβ expression was 9.79 years, while in high ERβ expression patients, it was 8.01 years, which was significantly lower compared with that of the low ERβ expression patients (P=0.002). This evidence concerns the gene ESR2 and neoplasm.